This site is intended for Healthcare professionals only.

Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 16 drug formulations used for treating various ailments, including Acetyl Salicylic Acid, Calcium Carbonate tablets, Condoms, Ethyl Alcohol 70% Solution, Rifampicin and others.

Accounting for inflation, the ceiling prices have been increased by 4.2662%. The ceiling prices are applicable with effect from 01.4.2019

Some of the formulations whose price has been revised by the NPPA are Acetyl Salicylic Acid, Calcium Carbonate used as an antacid to relieve heartburn, acid indigestion, and upset stomach; Condoms, Ethyl Alcohol 70% Solution, Rifampicin are other formulations whose prices have been revised. The details of the medicines reads;

Also Read: NPPA revises price of Coronary Stents; Check out Details

Sl No Medicines Dosage form and Strength Unit Ceiling price (wef 1.4.2019 with WPI @


Existing S.O. No. & Date
(1) (2) (3) (4) (5) 6(a) 6(b)
1 Acetyl Salicylic Acid Tablet 300mg 1 Tablet 0.22149 1462(E) 02.04.2018
2 Calcium carbonate Tablet 250 mg 1 Tablet 1.91 1462(E) 02.04.2018
3 Calcium carbonate Tablet 500 mg 1 Tablet 1.90 1462(E) 02.04.2018
4 Condoms 1 Condom 8.93 1462(E) 02.04.2018
5 Dapsone Tablet 50 mg 1 Tablet 0.23095 1462(E) 02.04.2018
6 Daunorubicin Injection 20 mg Each Pack 417.84 1462(E) 02.04.2018
7 Ethyl Alcohol 70% Solution 1 ML 0.56 1462(E) 02.04.2018
8 Etoposide Capsules 100 mg 1 Capsule 59.25 1462(E) 02.04.2018
9 Framycetin Sulphate Cream 0.50% 1 GM 0.85 1462(E) 02.04.2018
10 Gentian Violet


1% 1 ML 0.06395 1462(E) 02.04.2018
11 Isoniazid Syrup 100 mg/5ml 1 ML 0.25295 1462(E) 02.04.2018
12 Medroxy Progesterone Acetate Tablet 5mg 1 Tablet 2.92 1462(E) 02.04.2018
13 Oral Poliomyelitis

vaccine (LA)

Solution 1 ML 118.02 1462(E) 02.04.2018
14 Praziquantel Tablet 600 mg 1 Tablet 28.21 1462(E) 02.04.2018
15 Rifampicin Tablet 450mg 1 Tablet 4.34 1462(E) 02.04.2018
16 Sodium Nitrite Injection 30mg/ml 1 ML 21.11 1462(E) 02.04.2018

The notice further adds;

  • All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services taxes as applicable, if any.
  • All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 4.2662% for year 2018 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO,
  • The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said
  • The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and
  • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
  • Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO,
  • The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of
  • The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act,
  • Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

Also Read: NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

Source: self
0 comment(s) on Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted